Indivior Pharmaceuticals, Inc.
INDV
$34.42
-$0.35-1.01%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 229.63% | 3,700.00% | 2,900.00% | 241.76% | 143.55% |
| Total Depreciation and Amortization | -29.17% | -24.00% | -20.00% | 75.00% | 118.18% |
| Total Amortization of Deferred Charges | -66.67% | -- | -- | 0.00% | 0.00% |
| Total Other Non-Cash Items | 19.12% | 27.91% | -100.00% | -61.80% | -37.61% |
| Change in Net Operating Assets | -3,400.00% | -620.24% | -458.70% | 86.03% | 121.74% |
| Cash from Operations | -118.35% | -175.00% | -175.00% | 183.10% | 212.37% |
| Capital Expenditure | -57.78% | -153.13% | -127.59% | -241.18% | -275.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -98.59% | -100.00% | -73.91% | 29.41% |
| Cash from Investing | -438.10% | -305.13% | -195.65% | -148.57% | -38.24% |
| Total Debt Issued | 47.29% | 47.29% | -- | -- | -- |
| Total Debt Repaid | -38.46% | -42.39% | 92.92% | -6,350.00% | -12,450.00% |
| Issuance of Common Stock | -50.00% | -50.00% | -33.33% | -33.33% | -50.00% |
| Repurchase of Common Stock | -164.35% | 14.67% | 93.33% | 66.49% | 15.44% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -260.00% | -450.00% | 0.00% | -- | -400.00% |
| Cash from Financing | -427.27% | 90.48% | 70.59% | 108.29% | 74.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -200.00% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -150.00% | -- | -- | -- | -- |
| Net Change in Cash | -238.46% | -258.87% | -4,233.33% | 148.92% | 171.72% |